Surgepays is trading 6.6% down at $0.14 on September 28; no company-specific catalyst for the decline has surfaced. - Recent company news includes a September 17 joint-venture letter of intent, but available sources do not link it to the drop. - Broader markets are weaker amid higher oil prices and Treasury yields after President Trump rejected Iran’s proposal; upcoming inflation and jobs data are also in focus. This is a plausible backdrop, not a confirmed direct cause.